Geneva Capital Management LLC Makes New $24.68 Million Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Geneva Capital Management LLC bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 788,478 shares of the company's stock, valued at approximately $24,679,000. Geneva Capital Management LLC owned about 0.46% of Option Care Health at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of OPCH. GSA Capital Partners LLP purchased a new position in shares of Option Care Health during the first quarter worth approximately $464,000. Envestnet Portfolio Solutions Inc. grew its position in shares of Option Care Health by 14.5% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 6,798 shares of the company's stock worth $228,000 after acquiring an additional 861 shares during the last quarter. ProShare Advisors LLC grew its position in shares of Option Care Health by 4.6% during the first quarter. ProShare Advisors LLC now owns 38,774 shares of the company's stock worth $1,300,000 after acquiring an additional 1,696 shares during the last quarter. Entropy Technologies LP purchased a new position in shares of Option Care Health during the first quarter worth approximately $267,000. Finally, SageView Advisory Group LLC purchased a new position in shares of Option Care Health during the first quarter worth approximately $85,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Truist Financial lowered their price objective on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday, November 1st. Barrington Research decreased their target price on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a research report on Thursday, October 31st. Jefferies Financial Group lowered shares of Option Care Health from a "buy" rating to a "hold" rating and decreased their target price for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. JMP Securities boosted their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a research report on Monday, September 30th. Finally, Bank of America lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $30.83.

Insider Activity at Option Care Health

In related news, CFO Michael H. Shapiro sold 23,217 shares of the business's stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares of the company's stock, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CFO Michael H. Shapiro sold 23,217 shares of the business's stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares of the company's stock, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Price Performance

Shares of NASDAQ:OPCH traded down $0.53 during midday trading on Wednesday, hitting $22.32. 774,065 shares of the stock were exchanged, compared to its average volume of 1,509,295. The stock has a market cap of $3.80 billion, a P/E ratio of 18.80, a PEG ratio of 2.37 and a beta of 1.32. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $22.20 and a twelve month high of $34.63. The company has a 50 day moving average price of $29.24 and a 200-day moving average price of $29.54.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.